TGA Approval

IDEFIRIX imlifidase 11 mg powder for concentrate for solution for infusion (391413)

ARTG ID

391413

ARTG Name

IDEFIRIX imlifidase 11 mg powder for concentrate for solution for infusion

Sponsor

Hansa Biopharma (Australia) Pty Ltd

ARTG Date

July 10, 2023

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered - Prescription

Sponsor Information

Sponsor Name

Sponsor Item Name

HANSA BIOPHARMA (AUSTRALIA) PTY LTD

https://medical-cdn.nocode.com/drug_tga/7b3f4133b29c23a250e8198bdf050c92.pdf

Ingredient Name

imlifidase

Empowering clinical research with data-driven insights and AI-powered tools.

IDEFIRIX imlifidase 11 mg powder for concentrate for solution for infusion (391413) - TGA 批准文号 | MedPath